| Revision as of 08:07, 19 January 2011 editPashihiko (talk | contribs)Extended confirmed users3,563 editsNo edit summary← Previous edit | Revision as of 16:17, 1 February 2011 edit undoLouisajb (talk | contribs)Extended confirmed users4,402 edits added chemblidNext edit → | ||
| Line 7: | Line 7: | ||
| | PubChem = 32800 | | PubChem = 32800 | ||
| | DrugBank = | | DrugBank = | ||
| | ChEMBL_Ref = {{ebicite|correct|EBI}} | |||
| | ChEMBL = 1121 | |||
| | KEGG = D05845 | | KEGG = D05845 | ||
| | C=49|H=62|N=10|O=16|S=3 | | C=49|H=62|N=10|O=16|S=3 | ||
Revision as of 16:17, 1 February 2011
Pharmaceutical compound | |
| Clinical data | |
|---|---|
| Other names | 1-De(5-oxo-L-proline)-2-de-L-glutamine- 5-L-methioninecaerulein, 3--3-(4-sulfooxyphenyl)propanoyl]amino]-4- methylsulfanyl-butanoyl]amino]acetyl]amino]-3- (1H-indol-3-yl)propanoyl]amino]-4-methylsulfanyl- butanoyl]amino]-3-propanoic acid |
| Routes of administration | Intravenous |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.042.384  |
| Chemical and physical data | |
| Formula | C49H62N10O16S3 |
| Molar mass | 1143.27 g/mol g·mol |
Sincalide (INN) is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas. It is the 8-amino acid C-terminal fragment of cholecystokinin, and also known as CCK-8.
Common adverse effects following administration include abdominal discomfort and nausea. These effects are more pronounced following rapid infusion.
External links
- KINEVAC (sincalide) on NIH.gov
 | This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |